Deciphering Tuberculous Meningitis: From Clinical Challenges to Novel Models and Pathogenic Pathways

Mohamad Mosa Mubarak1,2, Shahnawaz Majeed1, Hadiya Amin Kantroo1,2

  • 1Clinical Microbiology PK/PD Division, CSIR - Indian Institute of Integrative Medicine, Sanatnagar, Srinagar, 190005, India.

Insights

Tuberculosis meningitis (TBM) is a severe form of TB, with increased incidence post-COVID-19 due to treatment disruptions. Further research is crucial for better diagnostics and treatments for TBM.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Public Health

Background:

  • COVID-19 pandemic disrupted Tuberculosis (TB) treatment, leading to increased TB incidence.
  • Tuberculous Meningitis (TBM), a severe extra-pulmonary TB form, poses significant mortality and morbidity risks.
  • Existing literature requires comprehensive review to address critical research gaps in TBM.

Purpose of the Study:

  • To review and highlight key research gaps in Tuberculous Meningitis (TBM).
  • To identify areas for further investigation in TBM's clinical presentation, diagnosis, and treatment.
  • To explore TBM's pathogenesis, including the role of the blood-brain barrier, cellular contributions, inflammation, and host-pathogen genetics.

Main Methods:

  • Literature scan focusing on TBM epidemiology, clinical aspects, and pathogenesis.
  • Identification of research gaps in diagnostics, chemotherapy, surgical interventions, and molecular mechanisms.
  • Exploration of TBM's interaction with SARS-COVID-19 and the utility of in-vivo/in-vitro models.

Main Results:

  • TBM presents unique epidemiological challenges with high mortality and morbidity.
  • Significant knowledge gaps exist in timely TBM diagnosis and effective therapeutic strategies.
  • The role of the blood-brain barrier, brain cells, inflammation, Matrix Metalloproteinases, and host-pathogen genetics in TBM pathogenesis requires further elucidation.

Conclusions:

  • Addressing identified research gaps is essential for advancing TBM understanding and management.
  • Improved diagnostic tools and innovative treatments are needed for TBM.
  • Further research into TBM pathogenesis, including its interplay with COVID-19, will enhance prevention and control strategies.